Table 1. Baseline characteristics of 54 COVID-19 patients.
| n | Percentage | |
|---|---|---|
| Sex | ||
| Male | 31 | 57.4 |
| Female | 23 | 42.6 |
| Age (years) | ||
|---|---|---|
| <60 | 43 | 79.6 |
| ≥60 | 11 | 20.4 |
| Disease severity | ||
|---|---|---|
| Severe | 24 | 44.4 |
| Non severe | 30 | 55.6 |
| Comorbidity | ||
|---|---|---|
| Hypertension | 12 | 22.2 |
| Diabetes | 8 | 14.8 |
| Coronary heart disease | 4 | 7.4 |
| Chronic liver disease | 1 | 1.9 |
| Blood type | ||
|---|---|---|
| A | 21 | 38.9 |
| B | 16 | 29.6 |
| AB | 8 | 14.8 |
| O | 9 | 16.7 |
| Glucocorticoid treatment | ||
|---|---|---|
| Yes | 13 | 24.1 |
| No | 41 | 75.9 |
| Immunoglobulin treatment | ||
|---|---|---|
| Yes | 1 | 1.9 |
| No | 53 | 98.1 |
| Mean time from symptom onset to antibody test (days) ± SD | 247.5 ± 11.2 | |
| Mean length of hospital stay (days) ± SD | 16.4 ± 7.6 | |
| Mean duration of RNA shedding (days) ± SD | 14.1 ± 7.6 | |
SD: Standard deviation.